Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Covalon Technologies Ltd V.COV

Alternate Symbol(s):  CVALF

Covalon Technologies Ltd. is a Canada-based patient-driven medical device company that provides healthcare solutions for advanced wound care, infection control, and medical device coatings. The Company's solutions are designed for patients and made for care providers. The Company leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon's name, and by developing and commercializing medical products for other medical companies under development and license contracts. The Company has three proprietary platform technologies that have the potential to be developed into a number of medical devices and products: Collagen matrix, Antimicrobial silicone adhesive and Medical coatings. Its product type includes advanced wound care, antimicrobial dressings, collagen dressings, IV dressings, and perioperative dressings. Its brands include ColActive PLUS, CovaClear, CovaView, CovaWound, IV Clear, SurgiClear, and VALGuard.


TSXV:COV - Post by User

Bullboard Posts
Post by patmel1on Mar 24, 2012 8:13pm
379 Views
Post# 19714187

Big promises made, on a few fronts, but still no n

Big promises made, on a few fronts, but still no n

How much patience is needed? Big promises made, on a few fronts, but still no news

 

“We are also aggressively marketing Covalon's medical coating technologies into new specialties and markets.”

“We fully expect to announce additional deals in the near future, both within North America and Internationally.”

 

“Our medical product development pipeline was strengthened during fiscal 2011, as we re-focused our development efforts on market driven products. We currently have five products in the process of regulatory clearance and have obtained Health Canada clearance on two significant new products - IV Clear® and SurgiClear®.”

 

“Finally, Covalon is continuing to evaluate acquisition opportunities that have the potential to significantly add capabilities and new market opportunities.”

 

Mr. Brian Pedlar, President and CEO of Covalon Technologies Ltd.  Jan 27, 2012

 

and what about the annual AGM?  usually would have occured by now but still no news on it. Hmm, whats going on????

pm

Bullboard Posts